Seeking Alpha hatchet job, page-218

Without a partnership, what are people's thoughts on the need for a cap raise?

It is funny to see comments like these .....

.... apart from the fact you seem to be forgetting that we have a few partnerships already (Tasly, Grünenthal, Novartis) it amazes me that posters like yourself (naysayers) don't believe that the strong phase 3 CHF results will attract a partnership deal ?

You don't think that negotiations to a point have been happening for the last 12-18 months in relation to the CHF phase 3 trial based on a 'what if the results show x or y or z' basis ?

May I remind you all of the details of the CHF partnership deal over a decade ago prior to the 5+ year phase 3 positive trial results we are now seeing .... don't kid yourselves - a CHF partnership deal will come with a 9 digit upfront payment and possibly even mimic the equity investment of the previous deal ten years ago of 19.99% by the chosen pharma group - just sayin' (IMO of course)

https://www.genengnews.com/topics/t...-commercialize-mesoblast-stem-cell-therapies/

Cephalon Shells Out $350M to Commercialize Mesoblast Stem Cell Therapies


Cephalon is paying Mesoblast $130 million up front and will make a $220 million equity investment in the Australian firm as part of a collaboration to develop and commercialize adult mesenchymal precursor stem cell (MPC) therapies based on Mesoblast’s adult stem cell technology platform.